These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2901227)

  • 1. Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism.
    Miyauchi A; Amino N; Tamaki H; Kuma K
    Am J Med; 1988 Sep; 85(3):418-20. PubMed ID: 2901227
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effect of radioiodine therapy on the thyroid antibodies in the patients of Graves' disease with postirradiation hypothyroidism.
    Chang TC; Chang CC; Chen FW; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1986 Dec; 85(12):1177-82. PubMed ID: 2880926
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 8. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
    Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
    J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up study of thyroid stimulating-blocking antibodies in hypothyroid patients.
    Tamai H; Kasagi K; Hara T; Hidaka A; Morita T; Kuma K; Konishi J; Kumagai LF; Nagataki S
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):699-707. PubMed ID: 1982862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of both stimulating and blocking types of TSH-receptor antibodies in sera from three patients with primary hypothyroidism.
    Kasagi K; Takeda K; Goshi K; Takamatsu J; Hidaka A; Hatabu H; Misaki T; Iida Y; Kuma K; Konishi J
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):253-60. PubMed ID: 1971776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of thyroid stimulating antibody and thyroid stimulation blocking antibody determined by radioiodine uptake into FRTL-5 cells.
    Yoshikawa N; Nishikawa M; Horimoto M; Uno C; Taniguchi N; Inada M
    Endocrinol Jpn; 1989 Feb; 36(1):55-63. PubMed ID: 2567231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
    Kálmán K; Leövey A; Hauck M; Szabo J; Bako G
    Radiobiol Radiother (Berl); 1987; 28(5):576-9. PubMed ID: 2894705
    [No Abstract]   [Full Text] [Related]  

  • 14. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
    Zakarija M; Jin S; McKenzie JM
    J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating antibody in Graves' disease.
    Davies TF
    Lancet; 1984 Jun; 1(8391):1417-8. PubMed ID: 6145871
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of thyroid-stimulating antibodies in sera of patients with Graves' disease--clinical and experimental studies.
    Chen G; Ye WX
    J Tongji Med Univ; 1987; 7(1):35-9. PubMed ID: 2885423
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.